Evidence map›Paper›PMID 22718187›Full record

ArticleKidney international2012

Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

Bruce M Robinson, Lin Tong, Jinyao Zhang, Robert A Wolfe, David A Goodkin, Roger N Greenwood, Peter G Kerr, Hal Morgenstern, Yun Li, Ronald L Pisoni and 5 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Kidney international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03459807 (BOLD), which is not on this map. Cited by 71 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03459807 phase2completednot on this mapstarted 2018, after this paper: background citation

BOLD: A Trial of Blood Pressure Lowering in Dialysis

TypeinterventionalSponsorUniversity of California, San FranciscoRan2018 to 2018Enrolled50ConditionsBlood Pressure, End Stage Renal Disease on Dialysis (Diagnosis), Chronic Kidney Diseases, Chronic Kidney Disease Stage 5ArmsAnti-Hypertensive medications, Dry Weight Adjustment
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Guideline
  4. Pooled it
  5. Guideline
  6. Trial
  7. Treating Home Versus Predialysis Blood Pressure Among In-Center Hemodialysis Patients: A Pilot Randomized Trial.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2021
    Trial
  8. BP in Dialysis: Results of a Pilot Study.Journal of the American Society of Nephrology : JASN · 2018
    Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Bruce M RobinsonArbor Research Collaborative for Health, Ann Arbor, MI, USA. bruce.robinson@arborresearch.org
Lin Tong
Jinyao Zhang
Robert A Wolfe
David A Goodkin
Roger N Greenwood
Peter G Kerr
Hal Morgenstern
Yun Li
Ronald L Pisoni
Rajiv Saran
Francesca Tentori
Tadao Akizawa
Shunichi Fukuhara
Friedrich K Port

Funding

Quality Dialysis Outcomes & Practice Patterns Study (DOPPS) in hemodialysisK01DK087762 · NIDDK · ARBOR RESEARCH COLLABORATIVE FOR HEALTH · PI TENTORI, FRANCESCA · 2011 to 2015
$744k
NIDDK NIH HHS K01 DK087762
6 · The paper itself

Abstract

KDOQI practice guidelines recommend predialysis blood pressure <140/90 mm Hg; however, most prior studies had found elevated mortality with low, not high, systolic blood pressure. This is possibly due to unmeasured confounders affecting systolic blood pressure and mortality. To lessen this bias, we analyzed 24,525 patients by Cox regression models adjusted for patient and facility characteristics. Compared with predialysis systolic blood pressure of 130-159 mm Hg, mortality was 13% higher in facilities with 20% more patients at systolic blood pressure of 110-129 mm Hg and 16% higher in facilities with 20% more patients at systolic blood pressure of ≥160 mm Hg. For patient-level systolic blood pressure, mortality was elevated at low (<130 mm Hg), not high (≥180 mm Hg), systolic blood pressure. For predialysis diastolic blood pressure, mortality was lowest at 60-99 mm Hg, a wide range implying less chance to improve outcomes. Higher mortality at systolic blood pressure of <130 mm Hg is consistent with prior studies and may be due to excessive blood pressure lowering during dialysis. The lowest risk facility systolic blood pressure of 130-159 mm Hg indicates this range may be optimal, but may have been influenced by unmeasured facility practices. While additional study is needed, our findings contrast with KDOQI blood pressure targets, and provide guidance on optimal blood pressure range in the absence of definitive clinical trial data.

Indexed as

Blood PressureAustraliaComorbidityCross-Sectional StudiesEuropeFemaleHumansHypertensionJapanKidney Failure, ChronicLinear ModelsMaleMiddle AgedNew ZealandPractice Guidelines as TopicPractice Patterns, Physicians'

Identifiers

PMID22718187
PMCPMC3891306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.